Lesley Fallowfield

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

Ovarian cancer

4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Communicating sad, bad, and difficult news in medicine

Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomised controlled trial

Information needs of patients with cancer: results from a large study in UK cancer centres

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)